A stability-indicating peptide method should do more than report one main peak. The impurity pattern often contains mechanistic information about oxygen, pH, temperature, light, moisture and handling.
Start with plausible chemistry, not a peak label
Methionine and tryptophan can be oxidation-sensitive; asparagine and glutamine may deamidate; aspartyl sequences can isomerize or hydrolyse; peptide bonds can cleave under sequence- and condition-dependent stress. These are risk hypotheses. Retention time alone does not establish structure.
Use orthogonal evidence
LC-MS can connect a chromatographic peak with a mass shift, but co-elution, in-source behaviour and isobaric changes limit interpretation. Forced-degradation samples help demonstrate specificity and peak tracking. Where structural assignment matters, MS/MS, comparison with a characterised impurity, or another orthogonal technique may be necessary.
What procurement teams should request
A stability claim should identify formulation, container, concentration, storage condition, time points, acceptance criteria and the method used. Ask whether the method resolves the degradants expected for that sequence. Comparing percentages produced by unrelated methods or integration rules is not scientifically defensible.
Decision Table
| Pathway | Analytical clue | Important limitation |
|---|---|---|
| Oxidation | Often a positive mass shift and changed retention | Site assignment may need MS/MS |
| Deamidation | Small mass change; possible multiple products | Isomeric products can complicate separation |
| Isomerization | Retention shift with little/no mass change | MS alone may not distinguish it |
| Hydrolysis | Fragment ions and new chromatographic peaks | Fragment recovery may be unequal |
What Belongs in the Procurement File
The purchasing specification should name the material form, intended analytical use, methods, acceptance criteria, sample and lot identifiers, packaging, storage and change-notification requirements. The receiving record should reconcile those requirements with the vial, COA, raw or controlled analytical output and shipping history. For the broader framework, consult the 2026 wholesale buyer’s guide, the HPLC review and the mass-spectrometry review.
Frequently Asked Questions
Does every new HPLC peak represent degradation?
No. It may be a process impurity, system artefact, carryover or degradant; investigate with controls and orthogonal data.
Can MS prove chromatographic purity?
No. MS supports identity; chromatographic composition depends on separation and detector response.
Technical Reference
Primary or authoritative reference used for this article. Its findings should be applied only within the material, formulation and method conditions described.